Trials / Completed
CompletedNCT03845114
Insulin-based Strategies to Prevent Hypoglycemia During Two Types of Exercise
Reduction of Basal Insulin to Prevent Hypoglycemia During Two Types of Exercise in Adults and Adolescents With Type 1 Diabetes Using Insulin Pump Therapy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 37 (actual)
- Sponsor
- Institut de Recherches Cliniques de Montreal · Academic / Other
- Sex
- All
- Age
- 14 Years
- Healthy volunteers
- Not accepted
Summary
Regular exercise is associated with many health benefits for individuals with type 1 diabetes. However, immediate and delayed exercise-induced hypoglycemia is frequent and thus the main limiting factor for physical activity practice in this population. To reduce the risk of exercise-induced hypoglycemia, two types of adjustments may be considered by patients with type 1 diabetes : pre-meal insulin-dose reduction and carbohydrate supplements. Few evidence-based recommendations are available for patients using insulin pump to adjust insulin doses in order to limit exercise-induced hypoglycemia. The objective of this study is to address the magnitude of the needed reduction during two types of frequently practiced exercise (continuous vs. interval exercise) known to have a different impact on blood glucose reduction.
Detailed description
Each study participant will be admitted at IRCM one to five days after sensor insertion. Participants will be asked to change their pump catheter 24 to 36 hours prior to the intervention visit. On the day of the intervention visit, participants will have a standardized lunch (45-65g CHO for females and 60-80g CHO for males ) at 12:00 and will be asked not to eat afterwards (except for correction of hypoglycemia). Participants will be asked not to exercise (excluding light exercise such as walking or taking the stairs) the day before and the day of the intervention visit. Participants will be asked not to consume caffeine after 12:00 the day of the intervention. The day before the intervention and the day of the intervention, participants will be asked to refrain from alcohol consumption. Participants will be blinded to the strategy used during the exercise intervention. Participants will be admitted at IRCM at 14:00. A catheter will be installed for plasma glucose and insulin measurements. At 14:30, insulin basal rate will be reduced by 40% or 80% depending of randomization. At 15:30, participants will undertake a continuous exercise (60-minute exercise on the ergocycle at 60% of VO2 peak) or an interval exercise (2-minutes alternating intervals at 85% and 50% of VO2peak for 50-minutes, with 5-minutes at 45% VO2peak at the start and the end of exercise). As a safety measure, plasma glucose will be measured every 10 minutes. Participants will be blinded to sensor glucose levels as well as plasma glucose measurements. At 17:00, the participant will be discharged if glucose levels are above 5.5 mmol/L. Participants will be asked to eat a standardized dinner at home (45-65g CHO for females and 60-80g CHO for males). Participants will have the freedom to choose at what time they wish to have dinner but it will have to be similar on all intervention visits.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Continous exercise | 60-minute continuous exercise on the ergocycle at 60% of VO2 peak (moderate intensity). |
| OTHER | Interval exercise | Participants will perform a 60-minute interval exercise on the ergocycle at 60% of VO2 peak (moderate intensity). |
| OTHER | Reduction of basal insulin by 40% | Participant's insulin basal rate will be reduced by 40% 1 hour before exercise onset. |
| OTHER | Reduction of basal insulin by 80% | Participant's insulin basal rate will be reduced by 80% 1 hour before exercise onset. |
Timeline
- Start date
- 2019-06-30
- Primary completion
- 2023-12-15
- Completion
- 2024-08-30
- First posted
- 2019-02-19
- Last updated
- 2024-11-06
Locations
2 sites across 1 country: Canada
Source: ClinicalTrials.gov record NCT03845114. Inclusion in this directory is not an endorsement.